Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Chronic bronchitis patients undergo Pseudostat phase II trials

Aug. 9, 1996

Allotrap 2702 enters second phase II trials

Aug. 9, 1996

Sangstat initiates cyclosporine and azathioprine bioequivalence trials

Aug. 9, 1996

Peptech's PTL-78419 covered under U.S. and European patents

Aug. 9, 1996

SangStat's Thymoglobulin nearing phase III trials completion

Aug. 9, 1996

Peptech issued U.S. patent for GMDP as antiinflammatory agent

Aug. 9, 1996

American Home Products claims rapamycin compounds

Aug. 9, 1996

Immunostimulant series described by Takeda

Aug. 9, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Rapamycin esters from American Home Products

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...